Cover Image

History of diabetes is associated with reduced likelihood of achieving PASI75 and PASI90 at 12 months among psoriasis patients treated with biologics: A prospective analysis in the CorEvitas Psoriasis Registry

Saved in:

Bibliographic Details
Main Authors:	Clinton W. Enos, MD, MS (Author), Yolanda Munoz Maldonado, PhD (Author), Hyung-Joo Kang, MS (Author), Robert R. McLean, DSc, MPH (Author), Abby S. Van Voorhees, MD (Author)
Format:	Book
Published:	Elsevier, 2024-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The social value of a PASI 90 or PASI 100 response in patients with moderate-to-severe plaque psoriasis in Spain
by: Paulina Maravilla-Herrera, et al.
Published: (2023)

Impact of Disease Burden of Patients with Psoriasis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry
by: Andrew Blauvelt, et al.
Published: (2024)

Skin Clearance is Associated with Reduced Treatment Failure in Patients with Psoriasis: Real-World Evidence from the CorEvitas Psoriasis Registry
by: Robert R. McLean, et al.
Published: (2023)

Durability of Near-Complete Skin Clearance in Patients with Psoriasis Using Systemic Biologic Therapies: Real-World Evidence from the CorEvitas Psoriasis Registry
by: Robert R. McLean, et al.
Published: (2023)

Bio‐experienced psoriasis patients treated with anti‐interleukin monoclonal antibodies are less likely to achieve PASI 90, PASI 100, PASI ≤ 1 and ≤3: Results from a cohort of 305 patients
by: Flavia Manzo Margiotta, et al.
Published: (2024)

PASI (Psoriasis Area and Severity Index) in the evaluation of the clinical manifestations of psoriasis
by: A. A. Kubanov, et al.
Published: (2017)

PASI and PQOL-12 score in psoriasis : Is there any correlation?
by: Vikas Shankar, et al.
Published: (2011)

Impact of psoriasis disease severity and special area involvement on patient-reported outcomes in the real world: an analysis from the CorEvitas psoriasis registry
by: Bruce Strober, et al.
Published: (2024)

Impact of Disease Factors of Patients with Psoriasis and Psoriatic Arthritis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry
by: Philip J. Mease, et al.
Published: (2024)

Clinical evaluation of different therapeutic modalities in psoriasis by Pasi score
by: Neerja Puri, et al.
Published: (2013)

Psoriasis: correlation between severity index (PASI) and systemic treatment
by: Maria Flavia Pereira da Silva, et al.
Published: (2013)

Characterization of disease burden, treatment and comorbidities in a large, real-world cohort of patients with atopic dermatitis: The CorEvitas Atopic Dermatitis Registry
by: Jonathan I. Silverberg, MD, PhD, MPH, et al.
Published: (2024)

comment: Clinical evaluation of different therapeutic modalities in psoriasis by Pasi score
by: Hisayoshi Imanishi, et al.
Published: (2013)

Importância da variação do PASI realizado por diversos observadores Inter-rater concordance study of the PASI (Psoriasis Area and Severity Index)
by: Joana Ribeiro Costa de Faria, et al.
Published: (2010)

The Effects of Cardiometabolic Comorbidities on Biologic Treatment for Psoriasis with Respect to PASI Scores: A Qualitative Systematic Review
by: Osman A, et al.
Published: (2024)

Assessing the Impact of Improvements in PASI and Itch Scores on Patients' Quality of Life in the Treatment of Psoriasis
by: Gil Yosipovitch, et al.
Published: (2019)

Tobacco Smoking Interacted with Alcohol Drinking Could Increase the Failure of PASI75 Achievement at Week 8 Among Patients with Psoriasis: Findings Based on a Psoriasis Cohort
by: Shen F, et al.
Published: (2024)

Six-Month Real-World Study to Assess the Effectiveness of Ixekizumab After Switching from IL-23 Inhibitors and Other Biologic Therapies: The CorEvitas Psoriasis Registry
by: Mark Lebwohl, et al.
Published: (2024)

Is Clear Always Clear? Comparison of Psoriasis Area and Severity Index (PASI) and the Physician's Global Assessment (PGA) in Psoriasis Clearance
by: Albert G. Wu, et al.
Published: (2020)

Psoriasis: Correlation between severity index (PASI) and quality of life index (DLQI) based on the type of treatment
by: Ali Al Raddadi, et al.
Published: (2016)

Racial and Ethnic Differences in Sociodemographic, Clinical, and Treatment Characteristics Among Patients with Atopic Dermatitis in the United States and Canada: Real-World Data from the CorEvitas Atopic Dermatitis Registry
by: Jonathan I. Silverberg, et al.
Published: (2023)

Identifying Predictors of PASI100 Responses up to Month 12 in Patients with Moderate-to-severe Psoriasis Receiving Biologics in the Psoriasis Study of Health Outcomes (PSoHO)
by: April W. Armstrong, et al.
Published: (2024)

Exploring the Correlation between the PASI and DLQI Scores in Psoriasis Treatment with Topical Ointments Containing <i>Rosa × damascena</i> Mill. Extract
by: Diana Ioana Gavra, et al.
Published: (2024)

Disease burden among patients with atopic dermatitis treated with systemic therapy for 4-12 months: results from the CorEvitas Atopic Dermatitis Registry
by: Jonathan I. Silverberg, et al.
Published: (2023)

Disease burden and patient characteristics associated with systemic therapy utilization among adults with atopic dermatitis: data from CorEvitas Atopic Dermatitis Registry
by: Jonathan I. Silverberg, et al.
Published: (2024)

Association of disease duration and PASI response rates at week 12 in patients with moderate-to-severe plaque psoriasis receiving biologics in the real-world psoriasis study of health outcomes (PSoHO)
by: Andreas Pinter, et al.
Published: (2024)

Evaluasi Program Pembinaan Atletik di Pengcab PASI Kabupaten Kuningan
by: Budi Budi, et al.
Published: (2020)

Psoriasis Severity, Comorbidities, and Treatment Response Differ among Geographic Regions in the United States
by: Clinton W. Enos, et al.
Published: (2021)

Absolute and Relative Psoriasis Area and Severity Indices (PASI) for Comparison of the Efficacy of Ixekizumab to Etanercept and Placebo in Patients with Moderate-to-severe Plaque Psoriasis: An Integrated Analysis of UNCOVER-2 and UNCOVER-3 Outcomes
by: Luís Puig, et al.
Published: (2019)

KIPRAH PASUNDAN ISTRI (PASI) DI BANDUNG PADA TAHUN 1930-1970
by: Fuji Astuti, -
Published: (2019)

Comparison of Psoriasis Area and Severity Index (PASI) Scores in Patients Treated with Oral Methotrexate and A Combination of Oral Methotrexate and Narrow Band-Ultraviolet B (NB-UVB) Phototherapy
by: Ervina Rosmarwati, et al.
Published: (2022)

Psoriatic Foot Involvement is the Most Significant Contributor to the Inconsistency Between PASI and DLQI: A Retrospective Study from China
by: Yang J, et al.
Published: (2023)

Reseña bibliográfica: Pasi Sahlberg (2013). El cambio educativo en Finlandia; ¿Qué puede aprender el mundo?
by: Axel Didriksson Takayanagui
Published: (2017)

Pengaruh Metode Latihan Interval Ekstensif dan Intensif Terhadap Prestasi Lari 400 Meter Putra Atlet PASI Riau
by: Agus Sulastio
Published: (2016)

Pengaruh Metode Latihan Interval Ekstensif dan Intensif Terhadap Prestasi Lari 400 Meter Putra Atlet PASI Riau
by: Agus Sulastio
Published: (2016)

Pengaruh Metode Latihan Interval Ekstensif dan Intensif Terhadap Prestasi Lari 400 Meter Putra Atlet PASI Riau
by: Agus Sulastio
Published: (2016)

Perbedaan Kejadian Diare Akut Antara Anak Riwayat Pemberian Asi Eksklusif Dengan Anak Riwayat Pemberian Pasi Pada Usia 7-24 Bulan
by: Hapilah, Yessi Nur, et al.
Published: (2017)

Brodalumab to the Rescue: Efficacy and Safety of Brodalumab in Patients with Psoriasis and Prior Exposure or Inadequate Response to Biologics
by: Alan Menter, et al.
Published: (2020)

Facial psoriasis in a mask-like distribution
by: Cameron M.B. Zachary, MS, et al.
Published: (2021)

Perbedaan Angka Kejadian Infeksi Saluran Pernapasan Akut (ISPA) Antara Anak yang Diberi ASI Eksklusif dengan yang Diberi Pengganti ASI (PASI) pada Usia 7-24 Bulan
by: Dewi, Arum Laksmita, et al.
Published: (2017)